Application of Electromagnetic Navigation System in Pulmonary Nodule Localization

Starting soon · Not applicable

Conditions studied: Pulmonary Nodules, Early-Stage Lung Cancer

In brief

This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.

Key facts

Study ID

NCT07595120

Run by

Shanghai Pulmonary Hospital, Shanghai, China

People needed

400

Starts

2026-05-01

Expected to finish

2027-04-01

Last updated by the study team

2026-05-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-80 years, regardless of gender;
• Solitary single nodule, scheduled for lung nodule puncture and localization;
• Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm;
• Eastern Cooperative Oncology Group (ECOG) performance status score 0-2;
• Voluntary participation, with signed informed consent.

You may not qualify if…

• Not suitable for video-assisted thoracoscopic surgery;
• The distance between the center of the lesion and the dome of the diaphragm is < 3 cm;
• History of thoracic adhesion due to previous thoracotomy or pleural infection;
• Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization;
• Inability to complete follow-up or poor compliance.

Where it is running

• Shanghai Pulmonary Hospital — Shanghai, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.